SCHEMBL6540846

SCHEMBL6540846

CCOC(=O)c1cc(S(=O)(=O)c2ccc(CCNC(=O)C(F)(F)F)cc2)ccc1OC

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.46
NLRP3 Q96P20 3/20 0.46
PKM P14618 1/20 0.44
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6541443 0.92 PKM (0.44) KMT2ANLRP3PKMTSHR
SCHEMBL6682136 0.87 POLB (0.45) KMT2APKM
SCHEMBL6540597 0.87 CA1 (0.41) KMT2A
SCHEMBL6679300 0.86 NLRP3 (0.42) NLRP3
SCHEMBL6539909 0.86 LMNA (0.41) KMT2A
SCHEMBL6539542 0.86 TSHR (0.47) NLRP3TSHR
SCHEMBL6540889 0.85 CA1 (0.40)
SCHEMBL6805839 0.85 CA12 (0.41) KMT2A
SCHEMBL6541135 0.83 TSHR (0.50) NLRP3TSHR
SCHEMBL6544777 0.83 NAMPT (0.48) NLRP3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138462-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-07-15 US disclosed
EP-1389185-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-02-18 EP disclosed
WO-2002094770-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138462-A1 Aminoalcohol derivatives BPHL, FANCD2, HRH2 KMT2A 432/4885NLRP3 4535/4885PKM 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.